DK1523572T3 - Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination - Google Patents

Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination

Info

Publication number
DK1523572T3
DK1523572T3 DK03762684T DK03762684T DK1523572T3 DK 1523572 T3 DK1523572 T3 DK 1523572T3 DK 03762684 T DK03762684 T DK 03762684T DK 03762684 T DK03762684 T DK 03762684T DK 1523572 T3 DK1523572 T3 DK 1523572T3
Authority
DK
Denmark
Prior art keywords
targets
prevention
control
bacterial infections
serum
Prior art date
Application number
DK03762684T
Other languages
Danish (da)
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis filed Critical Mutabilis
Application granted granted Critical
Publication of DK1523572T3 publication Critical patent/DK1523572T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK03762684T 2002-07-09 2003-07-09 Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination DK1523572T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208636A FR2842210B1 (fr) 2002-07-09 2002-07-09 Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
PCT/EP2003/008209 WO2004005535A2 (fr) 2002-07-09 2003-07-09 Determinants a pathogenicite pouvant etre utilises comme cibles en vue du developpement de moyens de prevention et de controle d'infections bacteriennes et/ou de dissemination systemique

Publications (1)

Publication Number Publication Date
DK1523572T3 true DK1523572T3 (da) 2008-09-08

Family

ID=29763685

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03762684T DK1523572T3 (da) 2002-07-09 2003-07-09 Patogenicitetsdeterminanter, der kan anvendes som mål for udviklingsmetoder til forebyggelse og bekæmpelse af bakterielle infektioner og/eller systemisk dissemination

Country Status (12)

Country Link
US (3) US20060003393A1 (fr)
EP (1) EP1523572B1 (fr)
JP (1) JP2006515155A (fr)
AT (1) ATE394503T1 (fr)
AU (2) AU2003266246A1 (fr)
CA (1) CA2491847A1 (fr)
DE (1) DE60320797D1 (fr)
DK (1) DK1523572T3 (fr)
ES (1) ES2306891T3 (fr)
FR (1) FR2842210B1 (fr)
HK (1) HK1078902A1 (fr)
WO (1) WO2004005535A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
WO2004050846A2 (fr) * 2002-12-02 2004-06-17 Biosynexus Incorporated Acide teichoique a paroi en tant que cible pour therapies et vaccins anti-staphylococciques
SI2351772T1 (sl) 2005-02-18 2016-11-30 Glaxosmithkline Biologicals Sa Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
CN101203529A (zh) 2005-02-18 2008-06-18 诺华疫苗和诊断公司 来自脑膜炎/脓毒症相关性大肠杆菌的蛋白质和核酸
US20080002211A1 (en) * 2006-01-20 2008-01-03 The General Hospital Corporation System, arrangement and process for providing speckle reductions using a wave front modulation for optical coherence tomography
JP2010500399A (ja) 2006-08-16 2010-01-07 ノバルティス アーゲー 尿路病原性大腸菌由来の免疫原
CN102770443A (zh) 2009-07-16 2012-11-07 诺华有限公司 脱毒大肠杆菌免疫原
WO2017189632A1 (fr) * 2016-04-25 2017-11-02 Aperture Bio, LLC Systèmes, dispositifs et procédés d'analyse séquentielle d'échantillons matriciels complexes pour détection bactérienne de haute fiabilité et prédiction de sensibilité aux médicaments à l'aide d'un cytomètre de flux
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN115725607B (zh) * 2022-07-14 2023-11-28 山东第一医科大学附属省立医院(山东省立医院) 一种鼻疽诺卡菌的致病靶基因及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020121A (en) * 1995-09-29 2000-02-01 Microcide Pharmaceuticals, Inc. Inhibitors of regulatory pathways
US6570006B1 (en) * 1998-06-12 2003-05-27 University Of Guelph Bacterial gene and method of treating a gram negative bacterial infection
EP1914312A3 (fr) * 1998-11-09 2008-10-08 Microscience Limited Gènes et protéines de virulence, et leur utilisation
AU3584500A (en) * 1999-01-27 2000-08-18 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in escherichia coli
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique

Also Published As

Publication number Publication date
US20110236886A1 (en) 2011-09-29
JP2006515155A (ja) 2006-05-25
AU2003266246A1 (en) 2004-01-23
WO2004005535A2 (fr) 2004-01-15
FR2842210A1 (fr) 2004-01-16
FR2842210B1 (fr) 2012-12-14
ATE394503T1 (de) 2008-05-15
AU2009201727A1 (en) 2009-05-21
CA2491847A1 (fr) 2004-01-15
HK1078902A1 (en) 2006-03-24
US20070111229A1 (en) 2007-05-17
EP1523572B1 (fr) 2008-05-07
WO2004005535A3 (fr) 2004-11-18
ES2306891T3 (es) 2008-11-16
DE60320797D1 (de) 2008-06-19
EP1523572A2 (fr) 2005-04-20
US20060003393A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
HK1078902A1 (en) Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination
Nanda et al. Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions
Ushijima et al. Vibrio coralliilyticus strain OCN008 is an etiological agent of acute Montipora white syndrome
Burley et al. CRISPR-Cas, a prokaryotic adaptive immune system, in endodontic, oral, and multidrug-resistant hospital-acquired Enterococcus faecalis
Connolly et al. The host metabolite D-serine contributes to bacterial niche specificity through gene selection
Park et al. Development of multiplex PCR assay for simultaneous detection of Salmonella genus, Salmonella subspecies I, Salm. Enteritidis, Salm. Heidelberg and Salm. Typhimurium
Jeong et al. Draft genome sequence of the plant growth-promoting bacterium Bacillus siamensis KCTC 13613T
Hutcherson et al. Comparison of inherently essential genes of Porphyromonas gingivalis identified in two transposon‐sequencing libraries
Brüggemann et al. Genomics of Clostridium tetani
ATE438731T1 (de) Verfahren zur herstellung einer l-aminosäure unter verwendung eines bakteriums der familie enterobacteriaceae
Minnick et al. Developmental biology of Coxiella burnetii
Ibarra Caballero et al. Genome sequence of Xanthomonas arboricola pv. corylina, isolated from Turkish filbert in Colorado
Vincent et al. Genomic characterisation of environmental Pseudomonas aeruginosa isolated from dental unit waterlines revealed the insertion sequence IS Pa11 as a chaotropic element
Armin et al. Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture
Gualtieri et al. Draft genome sequence and annotation of the entomopathogenic bacterium Xenorhabdus szentirmaii strain DSM16338
WO2018004224A3 (fr) Nouveau microorganisme appartenant à la famille des sporichthyaceae et son utilisation
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
Ohnishi et al. Genome sequence of a Bacillus anthracis outbreak strain from Zambia, 2011
Sangal et al. Genomic analyses confirm close relatedness between Rhodococcus defluvii and Rhodococcus equi (Rhodococcus hoagii)
Orihuel et al. Physiological and proteomic response of Escherichia coli O157: H7 to a bioprotective lactic acid bacterium in a meat environment
Tabata et al. A streptolysin S homologue is essential for β-haemolytic Streptococcus constellatus subsp. constellatus cytotoxicity
Ang et al. Genome sequence of Parvimonas micra strain A293, isolated from an abdominal abscess from a patient in the United Kingdom
ATE523596T1 (de) Verfahren zur herstellung von polyhydroxyalkanoat
EP3932416A4 (fr) Composition pour améliorer, prévenir ou traiter des maladies osseuses ou des maladies métaboliques, comprenant une nouvelle souche lactobacillus sakei cvl-001 et son milieu de culture
Nasrin et al. Draft genome sequence of Bacillus amyloliquefaciens AP183 with antibacterial activity against methicillin-resistant Staphylococcus aureus